A 28-year-old male presented with a rare case of primary intramedullary spinal Langerhans cell histiocytosis (LCH) manifesting as the chief complaint of a 6-month history of gait disturbance and back pain, and difficulty with sphincter control. Serial T 2 -weighted magnetic resonance imaging of the thoracic spine revealed enlargement and intramedullary hyperintensity of the spinal cord at T2 to T4. Biopsy of the lesion was performed. Histological examination of the biopsy specimens verified vascular proliferation and remarkable infiltration of histiocytes that were positive for CD1a, suggesting a diagnosis compatible with LCH. The patient was treated successfully by steroid pulse therapy. LCH is a rare disease that occurs mainly in children and may cause a broad range of manifestations, from a single osseous lesion to multiple lesions involving more than one organ or system. The present case illustrates the unexpected occurrence and important differential diagnosis of primary intramedullary spinal LCH of the thoracic spine in adult patients presenting with progressive paraparesis and back pain.
Introduction
Langerhans cell histiocytosis (LCH) is a clonal proliferation of Langerhans cells occurring as an isolated lesion or as part of systemic proliferation. 25, 26) The designation of LCH has now replaced the previous nomenclature of the group of diseases termed histiocytosis X, eosinophilic granuloma of the bone, Hand-Sch äuller-Christian disease, or Letterer-Siwe disease. 15) The etiology of the tumor is still controversial, 13, 14, 16, 25, 26) although clonal proliferation 25, 26) or viral etiology 13, 16) have been proposed. LCH most commonly occurs in the first two decades of life, as 80% of the patients are younger than 10 years old 13, 14, 16, 21) and most patients are males. 2, 16) The diagnosis of LCH in adults is rare. 14, 16, 21) The clinical manifestations and course are highly variable, and range from a self-healing solitary lesion to fatal, multi-organ involvement. LCH is classified into three distinct types: single-system single site (SS-s), single-system multisites (SSm), and multisystem (MS). An epidemiological study in Japan has reported that the SS-s, SS-m, and MS types of LCH are diagnosed at a ratio of almost 1:1:1. 12) LCH is known to involve many tissues including the central nervous system. Brain involvement most commonly occurs by contiguous spread from the cranium and sinuses. 3, 4, 17) Spinal cord involvement is rare, and usually occurs by direct extension from the surrounding bone tissue, but may also arise as metastatic spread from other tissues. 1, 5, 8, 9, 11, 15, 17, 20, 22, 24, 27) Isolated extramedullary or intramedullary lesion of the spinal cord is extremely rare. 10, 24) We report an extremely rare case of primary intramedullary spinal LCH of the thoracic spine.
Case Report
A 28-year-old male was admitted with the chief complaint of a 6-month history of gait disturbance and back pain. He also had difficulty with sphincter control. Neurological examination on admission showed spastic mild paraparesis, mild hypalgesia, and decreased deep sensation on the right lower extremity. Laboratory investigations did not suggest any possibility of spinal inflammatory disease. T 2 -weighted magnetic resonance (MR) imaging of the thoracic spine revealed enlargement and intramedullary hyperintensity of the spinal cord at T2 to T4. These changes in MR images apparently progressed over one month (Fig. 1A, B) . T 1 -weighted MR images with contrast medium showed increased intensity within the dorsolateral aspect of the spinal cord at T3 (Fig. 1C) . No lesions or involvement of the adjacent tissues was noted. Radiography and computed tomography, including the cervical spine and chest, detected no abnormalities.
The patient underwent a T3 to T5 osteoplastic laminotomy for partial resection of the tumor. The spinal (Fig.  2B) , so only biopsy of the tumor was performed. Frozensection examination of the biopsy specimens revealed invasion of inflammatory cells, but not suggesting anaplastic nature of the tumor. Histological examination of the biopsy specimens verified vascular proliferation and remarkable infiltration of histiocytes that were positive for CD1a, suggesting a diagnosis compatible with LCH (Fig.  3) .
Fluorine-18 fluorodeoxyglucose positron emission tomography ([ 18 F]FDG-PET) and technetium-99 scintigraphy of the whole skeleton showed no other lesion. Following steroid pulse treatment, MR imaging revealed remarkable improvement of the enlargement and intramedullary hyperintensity of the spinal cord (Fig. 4A) .
[ 18 F]FDG-PET, obtained 3 months after the surgery, showed abnormal accumulation of FDG in the left lung, suggesting a possible diagnosis of lung LCH. Cessation of smoking resulted in disappearance of the lesion in the lung. The patient's neurological condition 12 months after surgery was stable but not significantly different than before surgery, and no recurrence was noted (Fig. 4B) . 
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Discussion
Isolated extramedullary or intramedullary lesion of the spinal cord is extremely rare (Table 1) . 10, 24) The first case of isolated LCH occurred exclusively in the spinal cord of the cervical spine. 24) The entire lesion was clearly visible on MR imaging of the spinal cord. Surgical verification of the tumor confirmed the extramedullary location of the LCH. The extramedullary spinal LCH was treated with local low-dose radiation which resulted in complete regression. Another extremely rare case was intramedullary spinal LCH of the cervical spine. 10 Several clinical studies have been performed to clarify the outcome of LCH, including the international clinical trials of the Histiocyte Society 6,7) and a clinical study of the Japan LCH Study Group. 18) However, there is no standard treatment for SS-s-type LCH. To date, only two studies have examined a large number of patients with singlesystem LCH. 18, 23) The prognosis of patients with SS-s-type LCH is generally good, so chemotherapy is not commonly prescribed. The DAL-HX 83/90 study reported that a response to initial therapy was seen in all SS-s patients and 18% of them experienced reactivation. 23) Response to initial therapy was seen in 99.3% of SS-s patients and 7% of those patients experienced reactivation. 19) The present case may be comparable to SS-s, and requires careful follow-up.
The long-term overall outcome of spinal LCH is still unclear and may not be entirely optimistic. This present extremely rare case of intramedullary spinal LCH of the thoracic spine illustrates the unexpected occurrence and important differential diagnosis in an adult patient presenting with progressive paraparesis and back pain. Multidisciplinary treatment should be standard, but further clinical investigation is required.
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